CCL20/CCR6 expression profile in pancreatic cancer

BackgroundCCL20 and its receptor CCR6 have been shown to play a role in the onset, development and metastatic spread of various gastrointestinal malignancies. In this study, the expression profile and clinical significance of the CCL20/CCR6 system in distinct benign, pre-malignant and malignant pancreatic tissues was investigated.MethodsUsing RealTime-PCR, enzyme-linked immunosorbent assay (ELISA), Western Blot and immunohistochemistry, we have analyzed the expression profile of CCL20/CCR6 in resection specimens from patients with chronic pancreatitis (CP) (n = 22), pancreatic cystadenoma (PA) (n = 11) and pancreatic carcinoma (PCA) (n = 25) as well as in the respective matched normal pancreatic tissues.ResultsCCL20 mRNA and protein was weakly expressed in normal pancreatic tissues and CP and PA specimens but significantly up-regulated in PCA (8-fold) as compared to the matched normal tissue (P < 0.05). Moreover, CCL20 mRNA and protein expression was significantly associated with advanced T-category in patients with PCA (P < 0.05). CCR6 mRNA showed a significant up-regulation in all three disease entities as compared to normal tissues (P < 0.05, respectively).ConclusionCCL20 and CCR6 were significantly up-regulated in PCA as compared to the normal pancreatic tissue and CCL20 was significantly associated with advanced T-category in PCA patients. This suggests that CCL20 and CCR6 play a role in the development and progression of PCA and may constitute potential targets for novel treatment strategies.

• Publication year

  2010

• Venue

  Journal of Translational Medicine

• Publication date

  2010-05-10

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1186/1479-5876-8-45PMID 20459729PMCID 2877001
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CXCL8/IL‐8 and CXCL12/SDF‐1α co‐operatively promote invasiveness and angiogenesis in pancreatic cancer

  2009cited by this paper
• TNM Classification of Malignant Tumours, 7th Edition

  2009cited by this paper
• Blockade of SDF-1/CXCR4 signalling inhibits pancreatic cancer progression in vitro via inactivation of canonical Wnt pathway

  2008cited by this paper
• CXCL14 expression and potential function in pancreatic cancer.

  2008cited by this paper
• Chemokine receptor CCR6 expression level and aggressiveness of prostate cancer

  2008cited by this paper
• The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas.

  2007cited by this paper
• Cancer Statistics, 2007

  2007cited by this paper
• Enhanced Expression and Clinical Significance of CC‐Chemokine MIP‐3α in Hepatocellular Carcinoma

  2006cited by this paper
• Chemokine receptor CCR6 expression level and liver metastases in colorectal cancer.

  2006cited by this paper
• Involvement of Chemokine Receptor CCR6 in Colorectal Cancer Metastasis

  2006cited by this paper
• Macrophage inflammatory protein-3alpha promotes pancreatic cancer cell invasion.

  2005influential reference
• Housekeeping gene variability in normal and cancerous colorectal, pancreatic, esophageal, gastric and hepatic tissues.

  2005cited by this paper
• Macrophage inflammatory protein-3α promotes pancreatic cancer cell invasion

  2005influential reference
• Co-localization of macrophage inflammatory protein-3alpha (Mip-3alpha) and its receptor, CCR6, promotes pancreatic cancer cell invasion.

  2004cited by this paper
• Increased Survival, Proliferation, and Migration in Metastatic Human Pancreatic Tumor Cells Expressing Functional CXCR4

  2004cited by this paper
• Enhanced Angiogenesis Due to Inflammatory Cytokines from Pancreatic Cancer Cell Lines and Relation to Metastatic Potential

  2004cited by this paper
• Cytokines in pancreatic carcinoma

  2004cited by this paper
• Cancer and the chemokine network

  2004cited by this paper
• The chemokine network in cancer--much more than directing cell movement.

  2004cited by this paper
• Expression of MIP-3alpha/CCL20, a macrophage inflammatory protein in oral squamous cell carcinoma.

  2003cited by this paper
• Macrophage inflammatory protein-3alpha (mip-3alpha) promotes pancreatic cancer cell invasion by upregulation of matrix metalloproteinase-9 (MMP-9) production

  2003cited by this paper
• Expression of MIP-3α/CCL20, a macrophage inflammatory protein in oral squamous cell carcinoma

  2003cited by this paper
• Prevention of primary nonfunction of canine islet autografts by treatment with pravastatin.

  2002cited by this paper
• Appendix redux

  2002cited by this paper
• REGULATION OF DENDRITIC CELL RECRUITMENT BY CHEMOKINES

  2002cited by this paper
• Requirement for the Chemokine Receptor Ccr6 in Allergic Pulmonary Inflammation

  2001cited by this paper
• Selective recruitment of CCR6‐expressing cells by increased production of MIP‐3α in rheumatoid arthritis

  2001cited by this paper
• CC‐chemokine receptor 6 and its ligand macrophage inflammatory protein 3α might be involved in the amplification of local necroinflammatory response in the liver

  2001cited by this paper
• Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays.

  2000cited by this paper
• Pancreatic cancer: State‐of‐the‐art care

  2000cited by this paper
• CCR6 mediates dendritic cell localization, lymphocyte homeostasis, and immune responses in mucosal tissue.

  2000cited by this paper
• Up-Regulation of Macrophage Inflammatory Protein-3α/CCL20 and CC Chemokine Receptor 6 in Psoriasis1

  2000cited by this paper
• Detection and localization of MIP‐3α/LARC/exodus, a macrophage proinflammatory chemokine, and its CCR6 receptor in human pancreatic cancer

  1999influential reference
• Detection and localization of Mip-3alpha/LARC/Exodus, a macrophage proinflammatory chemokine, and its CCR6 receptor in human pancreatic cancer.

  1999influential reference
• SchluÈ sselwoÈ rter

  1999cited by this paper
• Role of growth factors in pancreatic cancer.

  1998cited by this paper
• Selective Recruitment of Immature and Mature Dendritic Cells by Distinct Chemokines Expressed in Different Anatomic Sites

  1998cited by this paper
• TNM Classification of Malignant Tumors

  1998cited by this paper
• The risk of pancreatic cancer following pancreatitis: an association due to confounding?

  1997cited by this paper
• CCR6, a CC Chemokine Receptor that Interacts with Macrophage Inflammatory Protein 3α and Is Highly Expressed in Human Dendritic Cells

  1997cited by this paper
• Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors.

  1996cited by this paper
• MedCalc: a new computer program for medical statistics.

  1995cited by this paper
• Pancreatitis and pancreatic cancer: a population-based study.

  1994cited by this paper
• Pancreatitis and the risk of pancreatic cancer.

  1993cited by this paper
• Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group.

  1993cited by this paper
• Pancreatitis and the risk of pancreatic cancer

  1993cited by this paper

• KITENIN-CCL20 axis is a potential therapeutic target for modulating immunosuppressive tumor microenvironment in glioblastoma.

  2026cites this paper
• Interruption of cross-communication pathways alters the immune cell signature of pancreatic cancer and decreases tumor growth

  2026cites this paper
• CCR-CCL axes as key upstream influencers of pancreatic ductal adenocarcinoma: CCR2–CCL2, CCR5–CCL5, CCR4–CCL17/22, CCR6–CCL20, CCR7–CCL19/21

  2026cites this paper
• Benzofuran‐2‐Carboxamide Derivatives as Immunomodulatory Agents Blocking the CCL20‐Induced Chemotaxis and Colon Cancer Growth

  2024cites this paper
• The Role of Chemokines in Orchestrating the Immune Response to Pancreatic Ductal Adenocarcinoma

  2024cites this paper
• Advance in the role of chemokines/chemokine receptors in carcinogenesis: Focus on pancreatic cancer.

  2024cites this paper
• Prognostic role of chemokine-related genes in acute myeloid leukemia

  2024cites this paper
• Progress of CCL20-CCR6 in the airways: a promising new therapeutic target

  2024cites this paper
• CCR6 as a Potential Target for Therapeutic Antibodies for the Treatment of Inflammatory Diseases

  2023cites this paper
• Laminin 332 expression levels predict clinical outcomes and chemotherapy response in patients with pancreatic adenocarcinoma

  2023cites this paper
• RBPJ Deficiency Sensitizes Pancreatic Acinar Cells to KRAS-Mediated Pancreatic Intraepithelial Neoplasia Initiation

  2023cites this paper
• Identification of cell types in multiplexed in situ images by combining protein expression and spatial information using CELESTA

  2022cites this paper
• The Exploration of Chemokines Importance in the Pathogenesis and Development of Endometrial Cancer

  2022cites this paper
• Tumour microenvironment and heterotypic interactions in pancreatic cancer

  2022cites this paper
• CCR4 is a prognostic biomarker and correlated with immune infiltrates in head and neck squamous cell carcinoma

  2021cites this paper
• Chemokine Receptor Antagonists: Role in Oncology

  2021cites this paper
• Centromere protein F is identified as a novel therapeutic target by genomics profile and contributing to the progression of pancreatic cancer.

  2020cites this paper
• EGFR/Ras-induced CCL20 production modulates the tumour microenvironment

  2020cites this paper
• OTT_A_263047 8125..8140

  2020cites this paper
• Chronic Pancreatitis and the Development of Pancreatic Cancer.

  2020cites this paper
• Common transcriptional programs and the role of chemokine (C-C motif) ligand 20 (CCL20) in cell migration of cholangiocarcinoma

  2020cites this paper
• Development and Validation of a Novel 8 Immune Gene Prognostic Signature Based on the Immune Expression Profile for Hepatocellular Carcinoma

  2020cites this paper
• CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of Receptors CCR5, CCR6, CCR7, CCR8, CCR9, and CCR10 Ligands

  2020cites this paper
• Role of Chemokines and Chemokine Receptors in Cancer

  2020cites this paper
• Clinical Significance of Selected Chemokines in Thyroid Cancer

  2019cites this paper
• Clinical significance and prospective molecular mechanism of C-C motif chemokine receptors in patients with early-stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy

  2019cites this paper
• NF-κB Dependent Chemokine Signaling in Pancreatic Cancer

  2019cites this paper
• γδ T cells in cancer: a small population of lymphocytes with big implications

  2019cites this paper
• Fusobacterium nucleatum and colorectal cancer: A mechanistic overview

  2018cites this paper
• Targeting Purinergic Receptor P2Y2 Prevents the Growth of Pancreatic Ductal Adenocarcinoma by Inhibiting Cancer Cell Glycolysis

  2018cites this paper
• Pleiotropic Immune Functions of Chemokine Receptor 6 in Health and Disease

  2018cites this paper
• Functional Role of the Chemokine Receptor XCR1 and its Bioengineered Ligand in Oral Squamous Cell Carcinoma (OSCC)

  2018cites this paper
• Sparse common component analysis for multiple high-dimensional datasets via noncentered principal component analysis

  2018cites this paper
• The Role of Chemokines in Thyroid Carcinoma

  2017cites this paper
• c‐Jun N‐terminal kinase in pancreatic tumor stroma augments tumor development in mice

  2017cites this paper
• CXCL12/CXCR4 display an inverse mRNA expression profile in gastric carcinoma which correlates with tumor progression

  2017cites this paper
• Gene Expression Profile of Renal Cell Carcinomas after Neoadjuvant Treatment with Sunitinib: New Pathways Revealed

  2017cites this paper
• Role of CCL20 mediated immune cell recruitment in NF-κB mediated TRAIL resistance of pancreatic cancer.

  2017cites this paper
• The role of exosomes in the pathogenesis of pancreatic ductal adenocarcinoma.

  2016cites this paper
• Histone deacetylase inhibitors inhibit metastasis by restoring a tumor suppressive microRNA-150 in advanced cutaneous T-cell lymphoma

  2016cites this paper
• Cytokines as Biomarkers of Pancreatic Ductal Adenocarcinoma: A Systematic Review

  2016cites this paper
• Learning Sparse Gaussian Graphical Models with Overlapping Blocks

  2016cites this paper
• NF-κB-Mediated CCL20 Reigns Dominantly in CXCR2-Driven Ovarian Cancer Progression

  2016cites this paper
• Disruption of CCL20-CCR6 interaction inhibits metastasis of advanced cutaneous T-cell lymphoma

  2016cites this paper
• Tumor-associated macrophage-derived CCL20 enhances the growth and metastasis of pancreatic cancer.

  2016cites this paper
• Prognostic significance of CCL 20 and its receptor CCR 6 in cancers : a meta-analysis

  2016cites this paper
• DOWN-REGULATION OF ATYPICAL CHEMOKINE RECEPTOR ACKR2/D6 EXPRESSION BY HEMATOPOIETIC PROGENITORS PROMOTES MYELOID CELL MOBILIZATION AND DIFFERENTIATION

  2016cites this paper
• Role of Chemokines and Chemokine Receptors in Cancer

  2015cites this paper
• Aryl Hydrocarbon Receptor Activation Synergistically Induces Lipopolysaccharide-Mediated Expression of Proinflammatory Chemokine (c-c motif) Ligand 20.

  2015cites this paper
• High serum macrophage inflammatory protein-3α is associated with the early recurrence or metastasis of non-small cell lung cancer following primary pulmonary resection

  2014cites this paper
• Expression profiles for 14-3-3 zeta and CCL20 in pancreatic cancer and chronic pancreatitis.

  2014cites this paper
• utations in BALB mitochondrial DNA induce CCL 20 up-regulation romoting tumorigenic phenotypes ames

  2014cites this paper
• Many Roles of CCL20: Emphasis on Breast Cancer.

  2014cites this paper
• CCL20/CCR6 promotes the invasion and migration of thyroid cancer cells via NF-kappa B signaling-induced MMP-3 production.

  2014cites this paper
• MicroRNA target prediction: theory and practice

  2014cites this paper
• Chemokines, chemokine receptors and the gastrointestinal system.

  2013cites this paper
• Macrophage inflammatory protein‐3 alpha (MIP‐3a) Is a novel serum prognostic marker in patients with colorectal cancer

  2013cites this paper
• Characteristics of chemokine signatures elicited by EGF and TNF in ovarian cancer cells

  2013cites this paper
• CCR6/CCL20 Chemokine Expression Profile in Distinct Colorectal Malignancies

  2013cites this paper
• Overexpression of CCL20 and its receptor CCR6 predicts poor clinical prognosis in human gliomas

  2012cites this paper
• Analysis of gene expression alterations in premalignant progression from normal mammary epithelium to ductal carcinoma in situ by multiple orthogonal tools

  2012cites this paper
• Molecular mechanisms of pancreatic cancer dissemination: the role of the chemokine system.

  2012cites this paper
• Overexpression of CCL20 and its receptor CCR6 predicts poor clinical prognosis in human gliomas

  2012cites this paper
• Differential Expression of Chemokine Receptors and their Roles in Cancer Imaging

  2012cites this paper
• High Expression of CCL20 Is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma after Curative Resection

  2012cites this paper
• Chemokines in health and disease.

  2011influential citation
• IgG-F-actin antibodies in celiac disease and dermatitis herpetiformis.

  2010cites this paper
• World Journal of Gastrointestinal Pathophysiology

  year unknowncites this paper
• Targeting Purinergic Receptor P 2 Y 2 prevents the growth of pancreatic ductal adenocarcinoma by inhibiting cancer cell glycolysis Running title : Targeting P 2 RY 2 signaling prevents the growth of PDAC

  year unknowncites this paper